comparemela.com

Latest Breaking News On - Biosciences trading down - Page 6 : comparemela.com

Ventyx Biosciences, Inc (NASDAQ:VTYX) Given Average Recommendation of Moderate Buy by Brokerages

Ventyx Biosciences, Inc (NASDAQ:VTYX) Given Average Recommendation of Moderate Buy by Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Castle Biosciences, Inc (NASDAQ:CSTL) Insider Derek J Maetzold Sells 1,947 Shares of Stock

Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) insider Derek J. Maetzold sold 1,947 shares of the firm’s stock in a transaction that occurred on Friday, April 12th. The shares were sold at an average price of $20.35, for a total value of $39,621.45. Following the completion of the sale, the insider now directly owns […]

Peregrine Capital Management LLC Sells 288,606 Shares of Coherus BioSciences, Inc (NASDAQ:CHRS)

Peregrine Capital Management LLC trimmed its stake in shares of Coherus BioSciences, Inc. (NASDAQ:CHRS – Free Report) by 20.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,089,961 shares of the biotechnology company’s stock after selling 288,606 shares […]

Tyra Biosciences (NASDAQ:TYRA) Stock Price Down 8 3%

Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Free Report) fell 8.3% during trading on Wednesday . The stock traded as low as $15.59 and last traded at $15.64. 42,517 shares changed hands during mid-day trading, a decline of 67% from the average session volume of 129,226 shares. The stock had previously closed at $17.05. […]

Carr Financial Group Corp Makes New Investment in Coherus BioSciences, Inc (NASDAQ:CHRS)

Carr Financial Group Corp purchased a new position in Coherus BioSciences, Inc. (NASDAQ:CHRS – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 35,195 shares of the biotechnology company’s stock, valued at approximately $117,000. A number of other hedge funds […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.